-
Ab110307-10μgMouse anti Human IL3RA/CD123 Antibody, Monoclonal (6H6), could be used for Flow and so on.Application:Flow: <: 0.5 μg/100w cellsProtein Function:This is a receptor for interleukin-3.
-
Ab110307-1mgMouse anti Human IL3RA/CD123 Antibody, Monoclonal (6H6), could be used for Flow and so on.Application:Flow: <: 0.5 μg/100w cellsProtein Function:This is a receptor for interleukin-3.
-
Ab110307-50μgMouse anti Human IL3RA/CD123 Antibody, Monoclonal (6H6), could be used for Flow and so on.Application:Flow: <: 0.5 μg/100w cellsProtein Function:This is a receptor for interleukin-3.
-
I336039-25mgImipramine N-oxide is the tertiary amine-oxidized form and a natural metabolite of the tricyclic serotonin/dopamine transport inhibitor Imipramine . FMO (Flavin-containing monooxygenase) enzymes are responsible for the oxidation of nucleophilic
-
I336039-5mgImipramine N-oxide is the tertiary amine-oxidized form and a natural metabolite of the tricyclic serotonin/dopamine transport inhibitor Imipramine . FMO (Flavin-containing monooxygenase) enzymes are responsible for the oxidation of nucleophilic
-
I288512-100mgProduct descriptionIN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and
-
I288512-10mgProduct descriptionIN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and
-
I288512-25mgProduct descriptionIN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and
-
I288512-50mgProduct descriptionIN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and
-
I288512-5mgProduct descriptionIN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and
-
Ab177861-100μgIndatuximab (anti-Syndecan-1) is an antibody against Syndecan-1.
-
Ab177861-10mgIndatuximab (anti-Syndecan-1) is an antibody against Syndecan-1.